Yuki Kageyama to Disease-Free Survival
This is a "connection" page, showing publications Yuki Kageyama has written about Disease-Free Survival.
Connection Strength
0.083
-
Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol. 2000 Dec; 30(12):553-6.
Score: 0.039
-
Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy. BJU Int. 2006 Jun; 97(6):1184-9.
Score: 0.014
-
Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma. Int J Urol. 2003 Aug; 10(8):445-8.
Score: 0.012
-
Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival. Urology. 2001 Sep; 58(3):462.
Score: 0.010
-
Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999 Oct; 36(4):309-13.
Score: 0.009